Latest market price
9.24
+0.25+2.78%
OverviewShort InterestFilings
ORICQT27ORIC Pharmaceuticals, Inc.·NASDAQ
9.24+2.78%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 23, 20268-KCurrent report
Oct 21, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 29, 20264Statement of changes in beneficial ownership
Sep 25, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 26, 2026144Notice of proposed sale of restricted securities
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Jul 30, 2026S-8Registration of employee benefit securities
Jul 30, 20268-KCurrent report
Jul 28, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 06, 2026144Notice of proposed sale of restricted securities
Jul 06, 2026144Notice of proposed sale of restricted securities
Jun 22, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 04, 202610-QQuarterly report
May 04, 20268-KCurrent report
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
#1 / 25 of 296
Page
▼
/ 12